Cyproheptadine Hydrochloride Tablet
Product Images NDC 52817-415

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 52817-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4mg-100s-count (4mg 100s Count)

Cyproheptadine Hydrochloride Tablets USP 4 mg label showing product name, strength, dosage form, and NDC 52817-415. The label includes storage instructions at 20° to 25°C, child-resistant container requirement, manufacturer Appco Pharma LLC, and distributor TruPharma, LLC. It also notes Rx only and package contains 100 tablets with revision date 05/2026.*

FDA Label Image

4mg-500s-count (4mg 500s Count)

Label for Cyproheptadine Hydrochloride Tablets, USP 4 mg, manufactured by Appco Pharma LLC and distributed by TruPharma, LLC. The label indicates oral tablets, Rx only, with a package size of 500 tablets. Dosage instructions and storage conditions are included, alongside a barcode and NDC 52817-415-50.*

FDA Label Image

Structure (Stru)

Chemical structure of Cyproheptadine Hydrochloride, showing a tricyclic ring system attached to a methylated piperidine ring, with molecular formula C21H21N•HCl and molecular weight 350.89.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.